Table 1.
All (n = 26,858) | Non-CASG members (n = 13,429) | CASG members (n = 13,429) | |
---|---|---|---|
| |||
Sex, n (%) | |||
Female | 20,020 (74.5) | 10,051 (74.8) | 9,969 (74.2) |
Male | 6,838 (25.5) | 3,378 (25.2) | 3,460 (25.8) |
Age at CASG eligibility (years), median [IQR] | 31.9 [25.9–40.0] | 31.5 [25.6–39.5] | 32.5 [26.4–40.4] |
Age at CASG eligibility (years), n (%) | |||
15–19 | 1,223 (4.55) | 731 (5.4) | 492 (3.7) |
20–24 | 4,469 (16.6) | 2,346 (17.5) | 2,123 (15.8) |
25–49 | 18,908 (70.4) | 9,231 (68.7) | 9,67, (72.1) |
50+ | 2,258 (8.4) | 1,121 (8.4) | 1,137 (8.5) |
Marital status, n (%) | |||
Cohabitating with partner | 9,415 (35.1) | 4,773 (35.5) | 4,642 (34.6) |
Married | 3,516 (13.1) | 1,770 (13.2) | 1,746 (13.0) |
Separated/divorced/widowed/single | 5,974 (22.2) | 2,900 (21.6) | 3,074 (22.9) |
Missing | 7,953 (29.6) | 3,986 (29.7) | 3,967 (29.5) |
Highest educational level attained, n (%) | |||
None | 5,397 (20.1) | 2,593 (19.3) | 2,804 (20.9) |
Primary school | 12,290 (45.8) | 6,142 (45.7) | 6,148 (45.8) |
Post-secondary | 2,937 (10.9) | 1,569 (11.7) | 1,368 (10.2) |
Missing | 6,234 (23.2) | 3,125 (23.3) | 3,109 (23.2) |
CD4 cell count (cells/mm3), median [IQR] | 375 [231–555] | 376 [232–556] | 373 [230–554] |
CD4 cell count (cells/mm3), n (%) | |||
<200 | 3,666 (13.6) | 1,779 (13.2) | 1,887 (14.1) |
200–349 | 4,715 (17.6) | 2,277 (17.0) | 2,438 (18.2) |
350–499 | 4,156 (15.5) | 1,994 (14.8) | 2,162 (16.1) |
≥500 | 5,712 (21.3) | 2,804 (20.9) | 2,908 (21.7) |
Missing | 8,609 (32.1) | 4,575 (34.1) | 4,034 (30) |
TB infection status at enrollment, n (%) | |||
No | 23,232 (86.5) | 11,502 (85.7) | 11,730 (87.3) |
Yes | 3,440 (12.8) | 1,799 (13.4) | 1,641 (12.2) |
Missing | 186 (0.7) | 128 (1.0) | 58 (0.4) |
Health facility location—district, n (%) | |||
Gilé | 1,920 (7.2) | 960 (7.2) | 960 (7.2) |
Ile | 1,102 (4.1) | 551 (4.1) | 551 (4.1) |
Inhassunge | 2,240 (8.3) | 1,120 (8.34) | 1,120 (8.3) |
Maganja da Costa | 2,964 (11) | 1482 (11) | 1,482 (11) |
Mocubela | 2,806 (10.4) | 1,403 (10.4) | 1,403 (10.4) |
Alto Molócué | 1,244 (4.6) | 622 (4.6) | 622 (4.6) |
Namacurra | 4,344 (16.2) | 2,172 (16.2) | 2,172 (16.2) |
Pebane | 5,936 (22.1) | 2,968 (22.1) | 2,968 (22.1) |
Quelimane | 4,302 (16) | 2,151 (16) | 2,151 (16) |
Health facility location, n (%) | |||
Periurban Quelimanea | 1,055 (3.9) | 534 (4) | 521 (3.9) |
Semiurban Quelimaneb | 3,262 (12.1) | 1,623 (12.1) | 1,639 (12.2) |
Rural districts | 22,541 (83.9) | 11,272 (83.9) | 11,269 (83.9) |
Time to first VL (days), median [IQR]c | 351 [165–645] | 358 [163–687] | 344 [169–606] |
Time to CASG eligibility (days), median [IQR] | 276 [188–640] | 273 [184–644] | 279 [194–636] |
Year of CASG eligibility, n (%) | |||
≤2013 | 2,678 (10) | 1,543 (11.5) | 1,135 (8.45) |
2014 | 4,733 (17.6) | 2,583 (19.2) | 2,150 (16) |
2015 | 6,133 (22.8) | 3,209 (23.9) | 2,924 (21.8) |
2016 | 6,570 (24.5) | 3,184 (23.7) | 3,386 (25.2) |
≥2017 | 6,744 (25.1) | 2,910 (21.7) | 3,834 (28.6) |
Periurban: urban health facilities in Quelimane District.
Semiurban: peripheral health facilities in Quelimane District.
Time to VL is derived from VL measurements obtained from 4,748 patients, which were used in the viral suppression analysis.
CASG, community adherence support group; CI, confidence interval; IQR, interquartile range; OR, odds ratio; TB, tuberculosis; VL, viral load.